GDRX - NASDAQ
GoodRx Holdings, Inc.
$2.81
-4.7%GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
At a Glance
Live SnapshotGoodRx Holdings, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.
CapEx Intensity
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Moderate working capital outflow. Typical for growing businesses, but ensure it's supporting revenue growth, not inefficiency.
Cash Flow Quality Insight
Exceptional cash generation: High-quality earnings converting to growing free cash flow. The company demonstrates strong pricing power, efficient operations, and disciplined capital allocation.
GoodRx Holdings, Inc. Cash Flow Statement
GDRX • NASDAQ
| GoodRx Holdings, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||
25M | 16.4M | -8.9M | -32.8M | -25.3M | -293.6M | 66M | 43.8M | |
81.7M | 69.5M | 111.8M | 54.2M | 34.5M | 18.4M | 13.6M | 9.8M | |
0.0 | -11.9M | -65.6M | -497K | 12.9M | -10.9M | -5.7M | -2.4M | |
58.7M | 99M | 104.8M | 120.2M | 160.5M | 397.3M | 3.7M | 1.8M | |
59M | 8.8M | 18.1M | 26M | 8M | 52.6M | 10.4M | 4.1M | |
(13.1M) | (23.6M) | (17.2M) | (4.4M) | (18.1M) | (29.2M) | (19.4M) | (11.7M) | |
-56.4M | 2.1M | -21.9M | -20.3M | -11.8M | -32.5M | -4.8M | -11.8M | |
167.9M | 183.9M | 138.3M | 146.8M | 178.8M | 131.3M | 83.3M | 45.3M | |
INVESTING ACTIVITIES | ||||||||
-2.3M | (0.0) | -1M | -4M | -4.6M | -20.6M | -1.4M | -3.5M | |
-30M | (0.0) | (0.0) | -155.3M | -144.3M | -55.8M | -31.3M | (0.0) | |
-87.7M | -70.3M | -54.7M | -51.2M | -29.9M | -15.3M | -4.3M | -2.7M | |
-120M | -70.3M | -55.8M | -210.5M | -178.7M | -91.6M | -37.1M | -3.5M | |
FINANCING ACTIVITIES | ||||||||
-206.9M | -158.8M | -104M | -101.7M | 0.0 | 991.8M | 1.6M | 0.0 | |
-3.8M | -167M | -5.3M | -7M | -7M | -7M | -57.2M | 606.9M | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -1.3B | |
-206.9M | -158.8M | -104M | -101.7M | (0.0) | (0.0) | (0.0) | (0.0) | |
-23.8M | -11.6M | -58.2M | -11.5M | -23.5M | -78.9M | 828K | 714.7M | |
-234.5M | -337.5M | -167.4M | -120.2M | -30.5M | 905.8M | -54.8M | -24.7M | |
CASH FLOW SUMMARY | ||||||||
-186.5M | -224M | -84.9M | -183.9M | -30.5M | 945.5M | -8.6M | 17.1M | |
448.3M | 672.3M | 757.2M | 941.1M | 971.6M | 26.1M | 34.6M | 17.5M | |
261.8M | 448.3M | 672.3M | 757.2M | 941.1M | 971.6M | 26.1M | 34.6M | |
164.4M | 113.5M | 82.5M | 91.6M | 144.3M | 95.5M | 77.5M | 41.8M |
SEC Filings
GDRX - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 06, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 06, 2026 | May 06, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 29, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | April 24, 2026 | April 23, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 03, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 27, 2026 | March 24, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 18, 2026 | March 14, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 06, 2026 | March 03, 2026 | 2026 | |
8-K 8-K 2026 N/A | February 27, 2026 | February 26, 2026 | 2026 | |
10-K 10-K 2025 FY FY | February 26, 2026 | December 31, 2025 | 2025 |
Related Guides
Continue your GDRX research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.